Hollow fiber bioreactor allows sustained production of immortalized mesenchymal stromal cell-derived extracellular vesicles

Abstract

Aim: Mesenchymal stromal cell-derived extracellular vesicles (MSC-EVs) have been reported to hold great potential as cell-free therapies due to their low immunogenicity and minimal toxicity. However, the large doses of MSC-EVs that are required for their clinical application highlight the urgency of finding a large-scale system for MSC-EV manufacture. In this study, we aimed to set up a hollow fiber bioreactor system for the continuous homogenous production of functional and high-quality MSC-EVs.

Methods: MSC lines from two donors were immortalized (iMSC) and inoculated into hollow fiber bioreactors. Throughout 4 weeks, conditioned medium was daily harvested. iMSC-EVs were purified and characterized for content, immunophenotype, size, and functionality and compared to 2D cultured iMSC.

Results: The iMSC inoculated into the bioreactor remained viable during the whole culture period, and they maintained their MSC phenotype at the end of EV production. Our results showed that the bioreactor system allows to obtain 3D-cultured iMSC-derived EVs (3D-EVs) that are comparable to flask (2D)-cultured iMSC-derived EVs (2D-EVs) in terms of protein and lipid content, size, and phenotype. We also confirm that 3D-derived EVs exhibit comparable functionality to 2D-EVs, showing pro-angiogenic potential in a dose-dependent manner.

Conclusions: These findings suggest that setting up a hollow fiber bioreactor system inoculating immortalized MSC lines facilitates the large-scale, functional, and high-quality production of iMSC-EVs. Our results emphasize the great potential of this production methodology to standardize EV production in the pursuit of clinical applications.

Keywords

Mesenchymal stromal cells (MSCs) / extracellular vesicles (EV) / advanced therapeutic medical product (ATMP) / Hollow fiber bioreactor (HFB) / immortalization / Large-scale / therapy

References

[1] Uccelli A,Pistoia V.Mesenchymal stem cells in health and disease.Nat Rev Immunol2008;8:726-36

[2] Le Blanc K,Ball L.Developmental Committee of the European Group for Blood and Marrow TransplantationMesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.Lancet2008;371:1579-86

[3] Duijvestein M,Roelofs H.Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study.Gut2010;59:1662-9

[4] Connick P,Crawley C.Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study.Lancet Neurol2012;11:150-6 PMCID:PMC3279697

[5] Cui LL,Bakreen A.The cerebral embolism evoked by intra-arterial delivery of allogeneic bone marrow mesenchymal stem cells in rats is related to cell dose and infusion velocity.Stem Cell Res Ther2015;6:11 PMCID:PMC4429328

[6] Volarevic V,Gazdic M.Ethical and safety issues of stem cell-based therapy.Int J Med Sci2018;15:36-45 PMCID:PMC5765738

[7] Poltavtseva RA,Lutsenko GV.Myths, reality and future of mesenchymal stem cell therapy.Cell Tissue Res2019;375:563-74

[8] Wiklander OPB,Lötvall J,El Andaloussi S.Advances in therapeutic applications of extracellular vesicles.Sci Transl Med2019;11:eaav8521 PMCID:PMC7104415

[9] van Niel G,Raposo G.Shedding light on the cell biology of extracellular vesicles.Nat Rev Mol Cell Biol2018;19:213-28.

[10] García-Bernal D,Yáñez RM.The current status of mesenchymal stromal cells: controversies, unresolved issues and some promising solutions to improve their therapeutic efficacy.Front Cell Dev Biol2021;9:650664 PMCID:PMC8007911

[11] Gimona M,Choo ABH.Critical considerations for the development of potency tests for therapeutic applications of mesenchymal stromal cell-derived small extracellular vesicles.Cytotherapy2021;23:373-80

[12] Patel DB,Santharam Y,Stroka KM.Impact of cell culture parameters on production and vascularization bioactivity of mesenchymal stem cell-derived extracellular vesicles.Bioeng Transl Med2017;2:170-9 PMCID:PMC5579732

[13] Jiang Y,Reinhardt RL.Pluripotency of mesenchymal stem cells derived from adult marrow.Nature2002;418:41-9

[14] Li XY,Zheng ZH,Wu ZB.Long-term culture in vitro impairs the immunosuppressive activity of mesenchymal stem cells on T cells.Mol Med Rep2012;6:1183-9

[15] Lian J,Liu C.Effects of serial passage on the characteristics and cardiac and neural differentiation of human umbilical cord Wharton’s jelly-derived mesenchymal stem cells.Stem Cells Int2016;2016:9291013

[16] Okamoto T,Nakayama T.Clonal heterogeneity in differentiation potential of immortalized human mesenchymal stem cells.Biochem Biophys Res Commun2002;295:354-61

[17] Simonsen JL,Serakinci N.Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells.Nat Biotechnol2002;20:592-6

[18] Balducci L,Saldarelli M.Immortalization of human adipose-derived stromal cells: production of cell lines with high growth rate, mesenchymal marker expression and capability to secrete high levels of angiogenic factors.Stem Cell Res Ther2014;5:63 PMCID:PMC4055112

[19] Gobin J,Mehic J.Hollow-fiber bioreactor production of extracellular vesicles from human bone marrow mesenchymal stromal cells yields nanovesicles that mirrors the immuno-modulatory antigenic signature of the producer cell.Stem Cell Res Ther2021;12:127 PMCID:PMC7880218

[20] Zhang Y,Zhang ZG.Systemic administration of cell-free exosomes generated by human bone marrow derived mesenchymal stem cells cultured under 2D and 3D conditions improves functional recovery in rats after traumatic brain injury.Neurochem Int2017;111:69-81 PMCID:PMC5311054

[21] Haraszti RA,Stoppato M.Exosomes produced from 3D cultures of MSCs by tangential flow filtration show higher yield and improved activity.Mol Ther2018;26:2838-47 PMCID:PMC6277553

[22] Yan IK,Borrelli DA. Use of a hollow fiber bioreactor to collect extracellular vesicles from cells in culture. In: Patel T, editor. Extracellular RNA. New York: Springer; 2018. pp. 35-41.

[23] Watson DC,Srivatsan A.Efficient production and enhanced tumor delivery of engineered extracellular vesicles.Biomaterials2016;105:195-205. PMCID:PMC7156278

[24] Monguió-Tortajada M,Gálvez-Montón C.Nanosized UCMSC-derived extracellular vesicles but not conditioned medium exclusively inhibit the inflammatory response of stimulated T cells: implications for nanomedicine.Theranostics2017;7:270-84 PMCID:PMC5197063

[25] Clos-Sansalvador M,Morón-Font M.N-Glycans in immortalized mesenchymal stromal cell-derived extracellular vesicles are critical for EV-cell interaction and functional activation of endothelial cells.Int J Mol Sci2022;23:9539 PMCID:PMC9455930

[26] ISCN 2020: an international system for human cytogenomic nomenclature (2020). Available from: https://karger.com/books/book/358/ISCN-2020An-International-System-for-Human [Last accessed on 10 May 2024]

[27] Fiber cell systems. Available from: https://www.fibercellsystems.com/ [Last accessed on 10 May 2024]

[28] Monguió-Tortajada M,Gámez-Valero A,Borràs FE.Extracellular-vesicle isolation from different biological fluids by size-exclusion chromatography.Curr Protoc Stem Cell Biol2019;49:e82

[29] Visnovitz T,Sódar BW.An improved 96 well plate format lipid quantification assay for standardisation of experiments with extracellular vesicles.J Extracell Vesicles2019;8:1565263 PMCID:PMC6352952

[30] Verta R,Tanzi A.Phenotypic and functional characterization of aqueous humor derived extracellular vesicles.Exp Eye Res2023;228:109393

[31] Skovronova R,Dimuccio V,Camussi G.Surface marker expression in small and medium/large mesenchymal stromal cell-derived extracellular vesicles in naive or apoptotic condition using orthogonal techniques.Cells2021;10:2948 PMCID:PMC8616318

[32] Kern S,Stoeve J,Bieback K.Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue.Stem Cells2006;24:1294-301

[33] Marino L,Rosamilio R.Mesenchymal stem cells from the Wharton's jelly of the human umbilical cord: biological properties and therapeutic potential.Int J Stem Cells2019;12:218-26 PMCID:PMC6657936

[34] Dominici M,Mueller I.Minimal criteria for defining multipotent mesenchymal stromal cells. the international society for cellular therapy position statement.Cytotherapy2006;8:315-7

[35] Burk J,Lauermann AF.Generation and characterization of a functional human adipose-derived multipotent mesenchymal stromal cell line.Biotechnol Bioeng2019;116:1417-26

[36] Cao H,Zhu H.Characterization of immortalized mesenchymal stem cells derived from foetal porcine pancreas.Cell Prolif2011;44:19-32 PMCID:PMC6496693

[37] Siska EK,Romano J.Generation of an immortalized mesenchymal stem cell line producing a secreted biosensor protein for glucose monitoring.PLoS One2017;12:e0185498 PMCID:PMC5614622

[38] Hanley PJ,Durett AG.Efficient manufacturing of therapeutic mesenchymal stromal cells with the use of the Quantum Cell Expansion System.Cytotherapy2014;16:1048-58 PMCID:PMC4087082

[39] Gámez-Valero A,Carreras-Planella L,Beyer K.Size-exclusion chromatography-based isolation minimally alters extracellular vesicles' characteristics compared to precipitating agents.Sci Rep2016;6:33641 PMCID:PMC5027519

[40] Benedikter BJ,Vajen T.Ultrafiltration combined with size exclusion chromatography efficiently isolates extracellular vesicles from cell culture media for compositional and functional studies.Sci Rep2017;7:15297 PMCID:PMC5681555

[41] Radeghieri A,Zendrini A.Cultured human amniocytes express hTERT, which is distributed between nucleus and cytoplasm and is secreted in extracellular vesicles.Biochem Biophys Res Commun2017;483:706-11

[42] Likonen D,Beery E.Exosomal telomerase transcripts reprogram the microRNA transcriptome profile of fibroblasts and partially contribute to CAF formation.Sci Rep2022;12:16415 PMCID:PMC9525320

[43] Goldvaser H,Beery E.Characterisation of blood-derived exosomal hTERT mRNA secretion in cancer patients: a potential pan-cancer marker.Br J Cancer2017;117:353-7 PMCID:PMC5537487

[44] Gutkin A,Beery E.Tumor cells derived exosomes contain hTERT mRNA and transform nonmalignant fibroblasts into telomerase positive cells.Oncotarget2016;7:59173-88 PMCID:PMC5312303

[45] Ahmed S,Ghaemmaghami AM.New generation of bioreactors that advance extracellular matrix modelling and tissue engineering.Biotechnol Lett2019;41:1-25 PMCID:PMC6313369

[46] Tasma Z,Damani T. Scale-up production of extracellular vesicles from mesenchymal stromal cells isolated from pre-implantation equine embryos. Available from: https://www.researchsquare.com/article/rs-1362793/v1 [Last accessed on 10 May 2024]

[47] Kornilov R,Mannerström B.Efficient ultrafiltration-based protocol to deplete extracellular vesicles from fetal bovine serum.J Extracell Vesicles2018;7:1422674 PMCID:PMC5795649

[48] Jakl V,Winkelmann M.A novel approach for large-scale manufacturing of small extracellular vesicles from bone marrow-derived mesenchymal stromal cells using a hollow fiber bioreactor.Front Bioeng Biotechnol2023;11:1107055 PMCID:PMC9904364

[49] Cao J,Tang T.Three-dimensional culture of MSCs produces exosomes with improved yield and enhanced therapeutic efficacy for cisplatin-induced acute kidney injury.Stem Cell Res Ther2020;11:206 PMCID:PMC7251891

[50] Théry C,Aikawa E.Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines.J Extracell Vesicles2018;7:1535750 PMCID:PMC6322352

[51] Monguió-Tortajada M,Moron-Font M.Local administration of porcine immunomodulatory, chemotactic and angiogenic extracellular vesicles using engineered cardiac scaffolds for myocardial infarction.Bioact Mater2021;6:3314-27 PMCID:PMC7973387

[52] Sharma M,Benny M.Mesenchymal stem cell-derived extracellular vesicles prevent experimental bronchopulmonary dysplasia complicated by pulmonary hypertension.Stem Cells Transl Med2022;11:828-40 PMCID:PMC9397655

[53] Lu G,Wang L.Neuroprotective effects of human-induced pluripotent stem cell-derived mesenchymal stem cell extracellular vesicles in ischemic stroke models.Biomedicines2023;11:2550 PMCID:PMC10525838

[54] Gangadaran P,Lee HW.Extracellular vesicles from mesenchymal stem cells activates VEGF receptors and accelerates recovery of hindlimb ischemia.J Control Release2017;264:112-26

[55] Kim J,Lee H,Bang OY.Clinical-scale mesenchymal stem cell-derived extracellular vesicle therapy for wound healing.Int J Mol Sci2023;24:4273 PMCID:PMC10001880